Kevin Kotler
Board Member
Heron Therapeutics, Inc. /De/ (HRTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kevin Kotler
Kevin Kotler is recorded as Board Member at Heron Therapeutics, Inc. /De/ (HRTX). Heron Therapeutics, Inc. /De/ reported in an 8-K filed December 21, 2023 that Kevin Kotler resigned as member of the board of directors, effective December 31, 2023. Heron Therapeutics, Inc. /De/ reported in an 8-K filed February 22, 2023 that Kevin Kotler was appointed director, effective February 21, 2023.
“On December 20, 2023, Kevin Kotler resigned as a member of the board of directors (the "Board") of Heron Therapeutics, Inc. (the "Company"), effective December 31, 2023.”
“Pursuant to the Cooperation Agreement, effective on February 21, 2023, the Board increased the size of the Board from seven to eight directors and appointed Adam Morgan, Craig Collard, and Kevin Kotler to the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-02-21–present
-
2023-02-21–2023-12-31
-
Start not stated–2023-12-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Heron Therapeutics, Inc. /De/
Other people whose current roles at this company are on record from its filings.
- Craig Collard CEO, Board Member
- Adam Morgan Chairman, Board Member
- Ira Duarte CFO, Chief Accounting Officer
- Mark Hensley COO
- Lisa Peraza Chief Accounting Officer
- Christian Waage Board Member
- Craig Johnson Board Member
- Michael Kaseta Board Member
- Sharmila Dissanaike Board Member
- Sharmila Dissanaike, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.